Suivre
David Gentien
David Gentien
Manager, Genomics platform, Translational Research Department, Institut Curie
Adresse e-mail validée de curie.fr
Titre
Citée par
Citée par
Année
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept …
C Le Tourneau, JP Delord, A Gonçalves, C Gavoille, C Dubot, N Isambert, ...
The lancet oncology 16 (13), 1324-1334, 2015
8832015
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
F André, T Bachelot, F Commo, M Campone, M Arnedos, V Dieras, ...
The lancet oncology 15 (3), 267-274, 2014
3912014
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
SJ Furney, M Pedersen, D Gentien, AG Dumont, A Rapinat, L Desjardins, ...
Cancer discovery 3 (10), 1122-1129, 2013
3722013
Molecular profiling of patient-derived breast cancer xenografts
F Reyal, C Guyader, C Decraene, C Lucchesi, N Auger, F Assayag, ...
Breast cancer research 14 (1), 1-14, 2012
1902012
Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast CancerPLK1 as a …
V Maire, F Némati, M Richardson, A Vincent-Salomon, B Tesson, G Rigaill, ...
Cancer research 73 (2), 813-823, 2013
1692013
Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges
B Piasecka, D Duffy, A Urrutia, H Quach, E Patin, C Posseme, J Bergstedt, ...
Proceedings of the National Academy of Sciences 115 (3), E488-E497, 2018
1492018
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts
S Huet, B Tesson, JP Jais, AL Feldman, L Magnano, E Thomas, ...
The Lancet Oncology 19 (4), 549-561, 2018
1472018
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors
F Némati, X Sastre-Garau, C Laurent, J Couturier, P Mariani, L Desjardins, ...
Clinical cancer research 16 (8), 2352-2362, 2010
1472010
TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer
V Maire, C Baldeyron, M Richardson, B Tesson, A Vincent-Salomon, ...
PloS one 8 (5), e63712, 2013
1402013
High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients
C Laurent, F Valet, N Planque, L Silveri, S Maacha, O Anezo, P Hupe, ...
Cancer research 71 (3), 666-674, 2011
1272011
The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer
R Chaligné, T Popova, MA Mendoza-Parra, MAM Saleem, D Gentien, ...
Genome research 25 (4), 488-503, 2015
1202015
Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
V Boeva, T Popova, M Lienard, S Toffoli, M Kamal, C Le Tourneau, ...
Bioinformatics 30 (24), 3443-3450, 2014
1062014
Sperm transcriptome profiling in oligozoospermia
D Montjean, P De La Grange, D Gentien, A Rapinat, S Belloc, ...
Journal of assisted reproduction and genetics 29 (1), 3-10, 2012
1002012
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
N Amirouchene-Angelozzi, F Nemati, D Gentien, A Nicolas, A Dumont, ...
Molecular Oncology 8 (8), 1508-1520, 2014
952014
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
P Cottu, E Marangoni, F Assayag, P De Cremoux, A Vincent-Salomon, ...
Breast cancer research and treatment 133 (2), 595-606, 2012
942012
Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in NeuroblastomactDNA Copy Number Profiling in Neuroblastoma
M Chicard, S Boyault, L Colmet Daage, W Richer, D Gentien, G Pierron, ...
Clinical Cancer Research 22 (22), 5564-5573, 2016
882016
Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas
J Calderaro, J Masliah-Planchon, W Richer, L Maillot, P Maille, L Mansuy, ...
European urology 69 (6), 1055-1061, 2016
822016
Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer
P Cottu, V D'Hondt, S Dureau, F Lerebours, I Desmoulins, PE Heudel, ...
Annals of Oncology 29 (12), 2334-2340, 2018
812018
Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal MelanomaCirculating Tumor DNA in Uveal Melanoma
J Madic, S Piperno-Neumann, V Servois, A Rampanou, M Milder, ...
Clinical Cancer Research 18 (14), 3934-3941, 2012
792012
Modulation of several waves of gene expression during FGF‐1 induced epithelial‐mesenchymal transition of carcinoma cells
C Billottet, M Tuefferd, D Gentien, A Rapinat, JP Thiery, P Broët, ...
Journal of cellular biochemistry 104 (3), 826-839, 2008
772008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20